Pregled bibliografske jedinice broj: 640799
From Asymptomatic to Symptomatic: a Cause of Nosebleed - Fatal Forty DDI: warfarin, amiodarone, CYP2C9
From Asymptomatic to Symptomatic: a Cause of Nosebleed - Fatal Forty DDI: warfarin, amiodarone, CYP2C9 // A Case Approach to Perioperative Drug-Drug Interactions / Marcucci, C ; Hutchens, MP ; Wittwer, ED ; Weingarten, TN ; Sprung, J ; et al. (ur.).
New York (NY): Springer, 2015. str. 669-673
CROSBI ID: 640799 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
From Asymptomatic to Symptomatic: a Cause of Nosebleed - Fatal Forty DDI: warfarin, amiodarone, CYP2C9
Autori
Markić, Joško ; Meštrović, Julije ; Sprung, Juraj
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
A Case Approach to Perioperative Drug-Drug Interactions
Urednik/ci
Marcucci, C ; Hutchens, MP ; Wittwer, ED ; Weingarten, TN ; Sprung, J ; et al.
Izdavač
Springer
Grad
New York (NY)
Godina
2015
Raspon stranica
669-673
ISBN
978-1-4614-7494-4
Ključne riječi
interaction, warfarin, amiodarone, CYP2C9
Sažetak
This case discusses amiodarone added to warfarin. Amiodarone is a cytochrome P450 2C9 inhibitor and the more actively anticoagulant S-enantiomer of warfarin is a 2C9 substrate. The interaction results in an enhanced anticoagulant effect.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split
